Projects per year
Abstract
Background: House dust mite (HDM) is the most common allergen trigger globally for allergic rhinitis and atopic asthma. Objectives: To expedite accurate confirmation of allergen sensitization, we designed fluorescent allergen tetramers to directly stain specific IgE on basophils to detect specific allergen sensitization using the flow cytometric CytoBas assay. Methods: Recombinant proteins of major HDM allergens (component), Der f 1, Der p 1, and Der p 2 were biotinylated and conjugated with fluorochrome streptavidins as tetramers. Blood samples from 64 patients who are HDM-allergic and 26 controls that are non–HDM-sensitized were incubated with allergen tetramers for evaluation of basophil binding (CytoBas) and activation (BAT) with flow cytometry. Results: The tetramers effectively bound and activated basophils from patients who are allergic but not from controls who are nonsensitized. CytoBas with Der p 1 as a single allergen had comparable sensitivity and specificity (92% and 100%) to BAT (91% and 100%) in detecting allergen sensitization, as did CytoBas with Der p 2 (95% and 96%) to BAT (95% and 87%). A positive staining for Der p 1 and/or Der p 2 in CytoBas was 100% sensitive and 96% specific for HDM allergy. Conclusions: CytoBas has diagnostic accuracy for group 1 and group 2 HDM allergens that is comparable to BAT, but with additional advantages of multiple allergen components in a single tube and no requirement for in vitro basophil activation. These findings endorse a single, multiplex CytoBas assay for accurate and component-resolved diagnosis of aeroallergen sensitization in patients with allergic asthma and/or rhinitis.
Original language | English |
---|---|
Pages (from-to) | 1282-1291 |
Number of pages | 20 |
Journal | The Journal of Allergy and Clinical Immunology |
Volume | 153 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2024 |
Keywords
- Allergic rhinitis
- asthma
- Der p 1
- Der p 2
- house dust mite
Projects
- 1 Finished
-
Molecular dissection of allergen sensitisation and immunotherapy: direct application to precision medicine in treatment of asthma
van Zelm, M. (Primary Chief Investigator (PCI)), O'Hehir, R. (Chief Investigator (CI)), Wines, B. (Chief Investigator (CI)) & Hew, M. (Chief Investigator (CI))
1/01/21 → 31/12/24
Project: Research